FDA Inspection 1160173 — Gfm Gesellschaft fur Micronisierung mbh
The FDA completed an inspection of Gfm Gesellschaft fur Micronisierung mbh on June 22, 2021 in Bremen. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 22, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bremen (Germany)
Additional Details
Mutual Recognition Agreement (MRA)